Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study

Journal of Physiology

Volumn 595, Issue 2, 2017, Pages 541-555

  Boets, Eef ^a,b   Gomand, Sara V ^b,c   Deroover, Lise ^a,b   Preston, Tom ^e   Vermeulen, Karen ^f   De Preter, Vicky ^a,g   Hamer, Henrike M ^a,b   Van den Mooter, Guy ^d   De Vuyst, Luc ^h   Courtin, Christophe M ^b,c   Annaert, Pieter ^d   Delcour, Jan A ^b,c   Verbeke, Kristin A ^a,b  

^a Gastro Intestinal Research Unit   (Belgium)

^b LEUVEN FOOD SCIENCE AND NUTRITION RESEARCH CENTRE LFORCE   (Belgium)

^c Center for Food and Microbial Technology   (Belgium)

^d DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^e SCOTTISH UNIVERSITIES ENVIRONMENTAL RESEARCH CENTRE   (United Kingdom)

^f GHENT UNIVERSITY   (Belgium)

^g Department of Obstetrics and Gynaecology   (Belgium)

^h VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

colonic fermentation; metabolism; short chain fatty acids; stable isotopes; systemic exposure

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CARBON 13; CARBON DIOXIDE; CHOLESTEROL; GLUCOSE; PROPIONIC ACID; SHORT CHAIN FATTY ACID; CARBON; MICROCAPSULE; VOLATILE FATTY ACID;

ARTICLE; COLON; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FECES ANALYSIS; GLUCONEOGENESIS; HUMAN; INTESTINE FLORA; ISOTOPE ANALYSIS; MOLECULAR STABILITY; OXIDATION KINETICS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; URINARY EXCRETION; ADULT; BLOOD; CROSSOVER PROCEDURE; FEMALE; MALE; METABOLISM; MICROBIOLOGY; MICROCAPSULE; NORMAL HUMAN; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; URINE; YOUNG ADULT;

ADULT; CAPSULES; CARBON ISOTOPES; CHOLESTEROL; COLON; CROSS-OVER STUDIES; FATTY ACIDS, VOLATILE; FEMALE; GASTROINTESTINAL MICROBIOME; GLUCOSE; HEALTHY VOLUNTEERS; HUMANS; MALE; YOUNG ADULT;

EID: 84988405277     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP272613     Document Type: Article

References (54)

1. Annison G, Illman RJ & Topping DL (2003). Acetylated, propionylated or butyrylated starches raise large bowel short-chain fatty acids preferentially when fed to rats. J Nutr 133, 3523–3528.
2. Bergman EN (1990). Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 70, 567–590.
3. Bjorntorp P & Sjostrom L (1978). Carbohydrate storage in man: speculations and some quantitative considerations. Metab Clin Exp 27, 1853–1865.
4. Bloemen JG, Venema K, van de Poll MC, Olde Damink SW, Buurman WA & Dejong CH (2009). Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin Nutr 28, 657–661.
5. Boets E, Deroover L, Houben E, Vermeulen K, Gomand SV, Delcour JA & Verbeke K (2015). Quantification of in vivo colonic short chain fatty acid production from inulin. Nutrients 7, 8916–8929.
6. Braden B, Lembcke B, Kuker W & Caspary WF (2007). C-13-breath tests: Current state of the art and future directions. Dig Liver Dis 39, 795–805.
7. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A & Dowell SJ (2003). The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278, 11312–11319.
8. Canfora EE, Jocken JW & Blaak EE (2015). Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11, 577–591.
9. Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S & Frost G (2015). Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744–1754.
10. Chourasia MK & Jain SK (2003). Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 6, 33–66.
11. Cook SI & Sellin JH (1998). Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther 12, 499–507.
12. De Preter V, Arijs I, Windey K, Vanhove W, Vermeire S, Schuit F, Rutgeerts P & Verbeke K (2012). Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Inflamm Bowel Dis 18, 1127–1136.
13. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Backhed F & Mithieux G (2014). Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84–96.
14. De Vuyst L & Leroy F (2011). Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int J Food Microbiol 149, 73–80.
15. den Besten G, Lange K, Havinga R, van Dijk TH, Gerding A, van Eunen K, Muller M, Groen AK, Hooiveld GJ, Bakker BM & Reijngoud DJ (2013a). Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am J Physiol Gastrointest Liver Physiol 305, G900–G910.
16. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ & Bakker BM (2013b). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54, 2325–2340.
17. Den Hond E, Hiele M, Evenepoel P, Peeters M, Ghoos Y & Rutgeerts P (1998). In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 115, 584–590.
18. Garber AJ, Menzel PH, Boden G & Owen OE (1974). Hepatic ketogenesis and gluconeogenesis in humans. J Clin Invest 54, 981–989.
19. Halestrap AP & Meredith D (2004). The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 447, 619–628.
20. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ & Brummer RJ (2008). Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104–119.
21. He T, Priebe MG, Harmsen HJ, Stellaard F, Sun X, Welling GW & Vonk RJ (2006). Colonic fermentation may play a role in lactose intolerance in humans. J Nutr 136, 58–63.
22. Helander HF & Fandriks L (2014). Surface area of the digestive tract – revisited. Scand J Gastroenterol 49, 681–689.
23. Hellerstein MK, Christiansen M, Kaempfer S, Kletke C, Wu K, Reid JS, Mulligan K, Hellerstein NS & Shackleton CH (1991). Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 87, 1841–1852.
24. Hellerstein MK, Schwarz JM & Neese RA (1996). Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 16, 523–557.
25. Hellman L, Rosenfeld RS & Gallagher TF (1954). Cholesterol synthesis from C14-acetate in man. J Clin Invest 33, 142–149.
26. Jani R, Molina M, Matsuda M, Balas B, Chavez A, DeFronzo RA & Abdul-Ghani M (2008). Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range. Diabetes care 31, 311–315.
27. Kien CL, Murray RD, Ailabouni A, Powers P, Kepner J, Powers L & Brunengraber H (1996). Stable isotope model for assessing production of short chain fatty acids from colon-derived sugar: application in pigs. J Nutr 126, 3069–3076.
28. Leng RA, Steel JW & Luick JR (1967). Contribution of propionate to glucose synthesis in sheep. Biochem J 103, 785–790.
29. Louis P & Flint HJ (2007). Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol 73, 2009–2012.
30. Maurer MJ, Schellekens RC, Wutzke KD & Stellaard F (2013). Isotope-labelled urea to test colon drug delivery devices in vivo: principles, calculations and interpretations. Isotopes Environ Health Stud 49, 473–491.
31. McNeil NI, Cummings JH & James WP (1978). Short chain fatty acid absorption by the human large intestine. Gut 19, 819–822.
32. Miller AA, Kurschel E, Osieka R & Schmidt CG (1987). Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23, 1283–1287.
33. Mittendorfer B, Sidossis LS, Walser E, Chinkes DL & Wolfe RR (1998). Regional acetate kinetics and oxidation in human volunteers. Am J Physiol Endocrinol Metab 274, E978–E983.
34. Morrison DJ, Cooper K, Waldron S, Slater C, Weaver LT & Preston T (2004). A streamlined approach to the analysis of volatile fatty acids and its application to the measurement of whole-body flux. Rapid Commun Mass Spectrom 18, 2593–2600.
35. Morrison DJ, Mackay WG, Edwards CA, Preston T, Dodson B & Weaver LT (2006). Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr 96, 570–577.
36. Paik MJ, Yu J, Hu MB, Kim SJ, Kim KR, Ahn YH, Choi S & Lee G (2008). Gas chromatographic-mass spectrometric analyses of cholesterol and its precursors in rat plasma as tert-butyldimethylsilyl derivatives. Clin Chim Acta 396, 62–65.
37. Perry TL, Hansen S, Diamond S, Bullis B, Mok C & Melancon SB (1970). Volatile fatty acids in normal human physiological fluids. Clin Chim Acta 29, 369–374.
38. Peters SG, Pomare EW & Fisher CA (1992). Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 33, 1249–1252.
39. Pouteau E, Piloquet H, Maugeais P, Champ M, Dumon H, Nguyen P & Krempf M (1996). Kinetic aspects of acetate metabolism in healthy humans using [1-13C] acetate. Am J Physiol Endocrinol Metab 271, E58–E64.
40. Previs SF & Brunengraber H (1998). Methods for measuring gluconeogenesis in vivo. Curr Opin Clin Nutr Metab Care 1, 461–465.
41. Renfurm LN, Bandsma RHJ, Verkade HJ, Hulzebos CV, van Dijk T, Boer T, Stellaard F, Kuipers F & Sauer PJJ (2004). Cholesterol synthesis and de novo lipogenesis in premature infants determined by mass isotopomer distribution analysis. Pediatr Res 56, 602–607.
42. Riviere A, Gagnon M, Weckx S, Roy D & De Vuyst L (2015). Mutual cross-feeding interactions between Bifidobacterium longum subsp. longum NCC2705 and Eubacterium rectale ATCC 33656 explain the bifidogenic and butyrogenic effects of arabinoxylan oligosaccharides. Appl Environ Microbiol 81, 7767–7781.
43. Schierbeek H, Moerdijk-Poortvliet TC, van den Akker CH, te Braake FW, Boschker HT & van Goudoever JB (2009). Analysis of [U-13C6]glucose in human plasma using liquid chromatography/isotope ratio mass spectrometry compared with two other mass spectrometry techniques. Rapid Commun Mass Spectrom 23, 3824–3830.
44. Simpson EJ, Chapman MA, Dawson J, Berry D, Macdonald IA & Cole A (2000). In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut 46, 73–77.
45. Turner S, Voogt J, Davidson M, Glass A, Killion S, Decaris J, Mohammed H, Minehira K, Boban D, Murphy E, Luchoomun J, Awada M, Neese R & Hellerstein M (2012). Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion. J Am Heart Assoc 1, e001826.
46. van Hall G (1999). Correction factors for 13C-labelled substrate oxidation at whole-body and muscle level. Proc Nutr Soc 58, 979–986.
47. Verbeke K, de Preter V, Geboes K, Daems T, van den Mooter G, Evenepoel P & Rutgeerts P (2005). In vivo evaluation of a colonic delivery system using isotope techniques. Aliment Pharmacol Ther 21, 187–194.
48. Vital M, Penton CR, Wang Q, Young VB, Antonopoulos DA, Sogin ML, Morrison HG, Raffals L, Chang EB, Huffnagle GB, Schmidt TM, Cole JR & Tiedje JM (2013). A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome 1, 8.
49. Vogt JA, Ishii-Schrade KB, Pencharz PB & Wolever TM (2004). L-Rhamnose increases serum propionate after long-term supplementation, but lactulose does not raise serum acetate. Am J Clin Nutr 80, 1254–1261.
50. Wang DC, Sun CH, Liu LY, Sun XH, Jin XW, Song WL, Liu XQ & Wan XL (2012). Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol Aging 33, 1057–1066.
51. Wiltrout DW & Satter LD (1972). Contribution of propionate to glucose synthesis in the lactating and nonlactating cow. J Dairy Sci 55, 307–317.
52. Wolever TM, Spadafora PJ, Cunnane SC, et al. (1995). Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans. Am J Clin Nutr 61, 1241–1247.
53. Wolfe RR & Jahoor F (1990). Recovery of labeled CO2 during the infusion of C-1- vs C-2-labeled acetate: implications for tracer studies of substrate oxidation. Am J Clin Nutr 51, 248–252.
54. Zhao G, Liu JF, Nyman M & Jonsson JA (2007). Determination of short-chain fatty acids in serum by hollow fiber supported liquid membrane extraction coupled with gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 846, 202–208.